The incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult population

American Journal of Gastroenterology

Volumn 106, Issue 1, 2011, Pages 130-138

  Porter, Chad K ^a   Gormley, Robert ^a   Tribble, David R ^b   Cash, Brooks D ^c   Riddle, Mark S ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONSTIPATION; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPEPSIA; FEMALE; GASTROINTESTINAL INFECTION; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SOLDIER;

ADULT; AGE DISTRIBUTION; CASE-CONTROL STUDIES; COMMUNICABLE DISEASES; CONFIDENCE INTERVALS; CONSTIPATION; DATABASES, FACTUAL; DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; GASTROENTERITIS; GASTROINTESTINAL DISEASES; HUMANS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; IRRITABLE BOWEL SYNDROME; LOGISTIC MODELS; MALE; MILITARY PERSONNEL; ODDS RATIO; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; UNITED STATES; YOUNG ADULT;

EID: 78650978167     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.371     Document Type: Article

References (71)

1. Corazziari E. Definition and epidemiology of functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2004; 18: 613-31.
2. Everhart JE. Functional intestinal disorders. In: Everhart JE (ed) The Burden of Digestive Diseases in the United States. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. US Government Printing Office: Washington, DC, 2008 NIH Publication No. 09-6443; pp. 77-87.
3. Ohman L, Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2001; 7: 163-73.
4. Hodgson S, Ioannides AS. Genetic testing in other GI diseases. Best Pract Res Clin Gastroenterol 2009; 23: 245-56.
5. Halvorson HA, Schlett CD, Riddle MS. Postinfectious irritable bowel syndrome- a meta-analysis. Am J Gastroenterol 2006; 101: 1894-9; quiz 1942.
6. Th abane M, Kottachchi DT, Marshall JK. Systematic review and metaanalysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007; 26: 535-44.
7. Mearin F, Perez-Oliveras M, Perello A et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005; 129: 98-104.
8. Parry SD, Stansfield R, Jelley D et al. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community- based, case-control study. Am J Gastroenterol 2003; 98: 1970-5.
9. Tuteja AK, Talley NJ, Gelman SS et al. Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. Dig Dis Sci 2008; 53: 271-6.
10. Sostek MB, Jackson S, Linevsky JK et al. High prevalence of chronic gastrointestinal symptoms in a National Guard Unit of Persian Gulf veterans. Am J Gastroenterol 1996; 91: 2494-7.
11. Marshall JK, Th abane M, Garg AX et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006; 131: 445-50; quiz 660.
12. Ji S, Park H, Lee D et al. Post-infectious irritable bowel syndrome in patients with Shigella infection. J Gastroenterol Hepatol 2005; 20: 381-6.
13. Dizdar V, Gilja OH, Hausken T. Increased visceral sensitivity in Giardiainduced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron. Neurogastroenterol Motil 2007; 19: 977-82.
14. Porter CK, Tribble DR, Aliaga PA et al. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology 2008; 135: 781-6.
15. Nelson L, Gormley R, Riddle MS et al. The epidemiology of Guillain-Barre Syndrome in U.S. military personnel: a case-control study. BMC Res Notes 2009; 2: 171.
16. Curry J, Gormley R, Riddle MS et al. The epidemiology of Reactive Arthritis in U.S. Military Personnel: A Case-Control Study. BMC Infectious Diseases 2010 (in press).
17. Rubertone MV, Brundage JF. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health 2002; 92: 1900-4.
18. Rudland S, Little M, Kemp P et al. The enemy within: diarrheal rates among British and Australian troops in Iraq. Mil Med 1996; 161: 728-31.
19. Hennessy TW, Marcus R, Deneen V et al. Survey of physician diagnostic practices for patients with acute diarrhea: clinical and public health implications. Clin Infect Dis 2004; 38 (Suppl 3): S203-11.
20. Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd edition, John Wiley & Sons, Inc.: New York, 2000.
21. Choung RS, Locke III GR, Schleck CD et al. Cumulative incidence of chronic constipation: a population-based study 1988-2003. Aliment Pharmacol Ther 2007; 26: 1521-8.
22. Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil 2008; 20 (Suppl 1): 121-9.
23. Shah ND, Chitkara DK, Locke GR et al. Ambulatory care for constipation in the United States, 1993-2004. Am J Gastroenterol 2008; 103: 1746-53.
24. Locke III GR, Yawn BP, Wollan PC et al. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther 2004; 19: 1025-31.
25. Garcia Rodriguez LA, Ruigomez A, Wallander MA et al. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol 2000; 35: 306-11.
26. Choudhury BK, Shi XZ, Sarna SK. Gene plasticity in colonic circular smooth muscle cells underlies motility dysfunction in a model of postinfective IBS. Am J Physiol Gastrointest Liver Physiol 2009; 296: G632-42.
27. Barbara G, Cremon C, Pallotti F et al. Postinfectious irritable bowel syndrome. J Pediatr Gastroenterol Nutr 2009; 48 (Suppl 2): S95-7.
28. Schoepfer AM, Schaffer T, Seibold-Schmid B et al. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil 2008; 20: 1110-8.
29. Wheatcroft J, Wakelin D, Smith A et al. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 2005; 17: 863-70.
30. Th ornley JP, Jenkins D, Neal K et al., Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J Infect Dis 2001; 184: 606-9.
31. Collins SM, Barbara G, Vallance B. Stress, inflammation and the irritable bowel syndrome. Can J Gastroenterol 1999; 13 (Suppl A): 47A-9A.
32. Kindt S, Tertychnyy A, de Hertogh G et al. Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil 2009; 21: 832-e56.
33. Lee KJ, Kim YB, Kim JH et al. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 2008; 23: 1689-94.
34. Pimentel M, Chatterjee S, Chang C et al. A new rat model links two contemporary theories in irritable bowel syndrome. Dig Dis Sci 2008; 53: 982-9.
35. Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol 2004; 18: 641-61.
36. Dunlop SP, Jenkins D, Neal KR et al. Randomized, double-blind, placebocontrolled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2003; 18: 77-84.
37. Glenn GM, Francis DH, Danielsen EM. Toxin-mediated Effects on the innate mucosal defenses: implications for enteric vaccines. Infect Immun 2009; 77: 5206-15.
38. Kalischuk LD, Buret AG. A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease? Am J Physiol Gastrointest Liver Physiol 2009; 298: G1-9.
39. Mearin F, Perello A, Balboa A et al. Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: results 3 years after gastroenteritis. Scand J Gastroenterol 2009; 44: 1173-85.
40. Mawe GM, Strong DS, Sharkey KA. Plasticity of enteric nerve functions in the inflamed and postinflamed gut. Neurogastroenterol Motil 2009; 21: 481-91.
41. Grover M, Herfarth H, Drossman DA. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel diseaseirritable bowel syndrome. Clin Gastroenterol Hepatol 2009; 7: 48-53.
42. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-88.
43. Parkes GC, BrostoffJ, Whelan K et al. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment. Am J Gastroenterol 2008; 103: 1557-67.
44. Locke III GR, Zinsmeister AR, Talley NJ et al. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol 2000; 95: 157-65.
45. Baretic M, Bilic A, Jurcic D et al. Epidemiology of irritable bowel syndrome in Croatia. Coll Antropol 2002; 26 (Suppl): 85-91.
46. Chang JY, Locke III GR, Schleck CD et al. Risk factors for chronic diarrhoea in the community in the absence of irritable bowel syndrome. Neurogastroenterol Motil 2009; 21: 1060-e87.
47. Wildner-Christensen M, Hansen JM, De Muckadell OB. Risk factors for dyspepsia in a general population: non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection. Scand J Gastroenterol 2006; 41: 149-54.
48. Moayyedi P, Forman D, Braunholtz D et al. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group. Am J Gastroenterol 2000; 95: 1448-55.
49. Howell SC, Quine S, Talley NJ. Low social class is linked to upper gastrointestinal symptoms in an Australian sample of urban adults. Scand J Gastroenterol 2006; 41: 657-66.
50. Zuckerman MJ, Guerra LG, Drossman DA et al. Health-care-seeking behaviors related to bowel complaints. Hispanics versus non-Hispanic whites. Dig Dis Sci 1996; 41: 77-82.
51. Taub E, Cuevas JL, Cook III EW et al. Irritable bowel syndrome defined by factor analysis. Gender and race comparisons. Dig Dis Sci 1995; 40: 2647-55.
52. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998; 93: 1816-22.
53. Everhart JE, Go VL, Johannes RS et al. A longitudinal survey of selfreported bowel habits in the United States. Dig Dis Sci 1989; 34: 1153-62.
54. Gwee KA, Graham JC, McKendrick MW et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150-3.
55. Chisick MC, Poindexter FR, York AK. Factors influencing perceived need for dental care by United States military recruits. Clin Oral Investig 1998; 2: 47-51.
56. Smith TC, Smith B, Ryan MA et al. Ten years and 100,000 participants later: occupational and other factors influencing participation in US Gulf War health registries. J Occup Environ Med 2002; 44: 758-68.
57. GoffSL, Feld A, Andrade SE et al. Administrative data used to identify patients with irritable bowel syndrome. J Clin Epidemiol 2008; 61: 617-21.
58. Ryan MA, Smith TC, Smith B et al. Millennium cohort: enrollment begins a 21-year contribution to understanding the impact of military service. J Clin Epidemiol 2007; 60: 181-91.
59. Benesch C, Witter Jr DM, Wilder AL et al. Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease. Neurology 1997; 49: 660-4.
60. Miller ML, Wang MC. Accuracy of ICD-9-CM coding of cervical spine fractures: implications for research using administrative databases. Annu Proc Assoc Adv Automot Med 2008; 52: 101-5.
61. Malik A, Dinnella JE, Kwoh CK et al. Poor validation of medical record ICD-9 diagnoses of gout in a veterans affairs database. J Rheumatol 2009; 36: 1283-6.
62. Smith B, Chu L, Smith T et al. Challenges of self-reported medical conditions and electronic medical records among members of a large military cohort. BMC Med Res Methodol 2008; 8: 37.
63. Skinner KM, Miller DR, Lincoln E et al. Concordance between respondent self-reports and medical records for chronic conditions: experience from the Veterans Health Study. J Ambul Care Manage 2005; 28: 102-10.
64. Levy RL, Olden KW, NaliboffBD et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006; 130: 1447-58.
65. Riddle MS, Halvorson HA, Shiau D et al. Acute gastrointestinal infection, respiratory illness, and noncombat injury among US military personnel during operation bright star 2005, in Northern Egypt. J Travel Med 2007; 14: 392-401.
66. Riddle MS, Sanders JW, Putnam SD et al. Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review. Am J Trop Med Hyg 2006; 74: 891-900.
67. Sanders JW, Putnam SD, Frankart C et al. Impact of illness and non-combat injury during Operations Iraqi freedom and enduring freedom (Afghanistan). Am J Trop Med Hyg 2005; 73: 713-9.
68. Sanders JW, Putnam SD, Riddle MS et al. Military importance of diarrhea: lessons from the Middle East. Curr Opin Gastroenterol 2005; 21: 9-14.
69. Riddle MS, Tribble DR, Cachafiero SP et al. Development of a travelers'diarrhea vaccine for the military: how much is an ounce of prevention really worth? Vaccine 2008; 26: 2490-502.
70. Lundkvist J, Steffen R, Jonsson B. Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers'diarrhea. J Travel Med 2009; 16: 28-34.
71. Stratton K, Durch JS, Lawrence et al. Vaccines for the 21st Century: A tool for Decisionmaking: Institute of Medicine of the National Academies. National Academies Press: Washington, DC, 2000, 476 pp.